News on Untranslated_Regions from BioPortfolio.com http://www.BioPortfolio.com Consolidated Untranslated_Regions news from BioPortfolio.com Wed, 10 Feb 2010 06:37:03 GMT en Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=0&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=0&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=1&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=1&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039835&HITNO=2&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039835&THISHREF=http://c.moreover.com/click/here.pl%3fz2538412816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039835&HITNO=2&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039835&THISHREF=http://c.moreover.com/click/here.pl%3fz2538412816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: AACN Announces Regions Fall Beacon Awardshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038916&HITNO=3&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038916&THISHREF=http://c.moreover.com/click/here.pl%3fz2537836044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038916&HITNO=3&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038916&THISHREF=http://c.moreover.com/click/here.pl%3fz2537836044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNurse.com: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034215&HITNO=4&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034215&THISHREF=http://c.moreover.com/click/here.pl%3fz2535682088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034215&HITNO=4&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034215&THISHREF=http://c.moreover.com/click/here.pl%3fz2535682088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=5&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=5&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033171&HITNO=6&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033171&THISHREF=http://c.moreover.com/click/here.pl%3fz2535047334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033171&HITNO=6&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033171&THISHREF=http://c.moreover.com/click/here.pl%3fz2535047334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWeb Newswire: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033015&HITNO=7&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033015&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033015&HITNO=7&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033015&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWebWire: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029254&HITNO=8&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029254&THISHREF=http://c.moreover.com/click/here.pl%3fz2533053861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029254&HITNO=8&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029254&THISHREF=http://c.moreover.com/click/here.pl%3fz2533053861%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031398&HITNO=9&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031398&THISHREF=http://c.moreover.com/click/here.pl%3fz2534189301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031398&HITNO=9&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031398&THISHREF=http://c.moreover.com/click/here.pl%3fz2534189301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029156&HITNO=10&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029156&THISHREF=http://c.moreover.com/click/here.pl%3fz2533010455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029156&HITNO=10&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029156&THISHREF=http://c.moreover.com/click/here.pl%3fz2533010455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031629&HITNO=11&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031629&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031629&HITNO=11&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031629&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: ::: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031487&HITNO=12&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031487&THISHREF=http://c.moreover.com/click/here.pl%3fz2534230781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031487&HITNO=12&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031487&THISHREF=http://c.moreover.com/click/here.pl%3fz2534230781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031346&HITNO=13&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031346&THISHREF=http://c.moreover.com/click/here.pl%3fz2534145977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031346&HITNO=13&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031346&THISHREF=http://c.moreover.com/click/here.pl%3fz2534145977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Active Biotech (SE) - Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030930&HITNO=14&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030930&THISHREF=http://c.moreover.com/click/here.pl%3fz2533900095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030930&HITNO=14&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Untranslated_Regions&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030930&THISHREF=http://c.moreover.com/click/here.pl%3fz2533900095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: